Molecular Carcinogenesis Flashcards

1
Q

what are the specific hallmarks of cancer cells (10)

A

self sufficiency in positive growth signalling - eg in RAS always on

evading growth suppressors - mutations in Rb to stop prevention of proliferation

avoiding immune destruction - binding PD1/PDL1 stops T cells

enabling replicative immortality - stop telomere shortening

promoting inflammation

activating invasion and metastasis

inducing angiogenesis - nutrients for tumour

genome instability and mutation (Bcl2 overexpression in cancers = anti-apoptotic)

resisting cell death

deregulated metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a proto-oncogene

A

normal genes that promote cell proliferation, survival and angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is an oncogene

A

mutation of protocol-oncogene causing cancerous cell - activity of expressed proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why are oncogenes so powerful genetically

A

dominant gain in function

1 mutant copy of gene acts dominantly to the remaining normal parental gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are some examples of oncogenes

A

RAS, myc, RAF, HER2 and EGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 4 steps mechanisms of oncogene activation

A

translocation
point mutation
amplification
insertion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe the specific 4 processes of oncogene activation

A

trasnlocaiton of oncogene from low to an active transcription site - aberrant expression of the oncogene
point mutation - substitution of single base within the amino acid sequence produces a hyperactive oncoprotein
amplification by insertion of multiple copies of an oncogene - increased expression
insertion for promoter or enhancing genes near an oncogene = increased expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the two types of tumour suppressor gene

A

gatekeeper - antioncogenes - negative regulators of the cell eye and proliferation - positive regulators of apoptosis

caretakers - maintain genetic stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are some examples of tumour suppressor genes

A

APC, P53, BRCA1/2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the mechanism of TSG loss

A

carcinogens induce molecular abnormalities in TSG/s which reduction protein function / expression
does this by inactivating point mutations, deletion, translocations, epigenetic silencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are familial cancer syndromes

A

caused by inheritance of a mutant copy of TSG gene which increases risk by 70-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how would familial transfer of a mutant caretaker gene lead to increased risk of cancer

A

genetic instability - predisposition to developing cancer - also needs to hit hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is required to turn a normal cell into a neoplastic cell

A

minimum of 3-6 genetic alterations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the mutagenic pathway of colorectal cancer from normal epithelium to adenocarcinoma

A
normal (APC)
early adenoma (KRAS)
intermediate adenoma (SMAD4)
late adenoma (P53) 
adenocarcenoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the uses of tumour markers

A

diagnosis - identification of type or subtype
prognosis - some confer worse survival
therapy - predict therapeutic response
monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are serum markers and what can they be used for

A

antigens of cancerous cells - not sensitive or specific enough for general screening but can be used as an adjunct (antra help)

17
Q

why types of cancerous cells can serum markers test for

A

AFP, hCG, PSA (prostate), CEA and thyroglobulin

18
Q

what marker is over expressed in 30% of breast cancers and how do we use this in treatment

A

HER2 - treat with herceptin

19
Q

what mutations do 50% of colorectal cancers have and how do we use this in treatment

A

KRAS mutation - permanently on from of RAS

therefore cannot give cetuximab or panitummuab

20
Q

what protein is over expressed in lung cancers

A

EGFR